2 unknown, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
Follow ALA: new trials by email Literature Review of ALA trials Research Report on ALA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention ALA - Actinic Keratoses | Phase 4 | Unknown | Shanghai Dermatology Hospital | 300 | 2018-08-30 | 2019-03-19 |
| Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel METHYLAMINOLEVULINATE HYDROCHLORIDE, AMINOLEVULINIC ACID HYDROCHLORIDE - Actinic Keratosis | Phase 4 | Unknown | Fundación Instituto Valenciano de Oncología | 50 | 2015-12-01 | 2016-01-06 |
| The Effect of A-lipoic Acid (ALA) on Fatty Acid-induced Impairment of Glucose-stimulated Insulin Secretion alpha lipoic acid - Type 2 Diabetes, Prediabetes | Phase 4 | Completed | University Health Network, Toronto | 15 | 2010-02-01 | 2012-10-02 |
Keratosis, Actinic (2) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Prediabetic State (1)
Fundación Instituto Valenciano de Oncología (1) · Shanghai Dermatology Hospital (1) · University Health Network, Toronto (1)
Canada (1) · China (1) · Spain (1)
Carlos Serra (1) · Xiuli Wang, PHD, MD (1)
PMID 22329784, PMID 24037822, PMID 24589500, PMID 24818175, PMID 25174261, PMID 25950503, PMID 26300464, PMID 26921093, PMID 27167413, PMID 28532759
2015 (1)